Founded with a mission to revolutionize gut health, Ombre offers personalized microbiome testing kits and probiotics aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. Their core product is an at-home microbiome test that provides a comprehensive analysis of gut bacteria, followed by a personalized report with actionable insights and targeted probiotic recommendations. Ombre focuses on enabling customers to address the root causes of gut problems through customized, science-backed solutions.
Ombre has garnered attention for its innovative approach to gut health, attracting notable investors and health experts in the field. The company has achieved significant milestones, including the development of a subscription-based service that delivers continuous updates and personalized probiotics tailored to individual needs. Ombre's impact is evident in its growing customer base, who benefit from improved gut health and overall wellness through their scientifically-driven, personalized care solutions.
